Dr. Epstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
621 Ridgely Ave
Ste 201
Annapolis, MD 21401Phone+1 410-224-4887Fax+1 410-224-1428
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Gastroenterology, 1984 - 1986
George Washington UniversityResidency, Internal Medicine, 1981 - 1984
Rutgers New Jersey Medical SchoolClass of 1981
Certifications & Licensure
MD State Medical License 1986 - 2026
FL State Medical License 2014 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (AGAF) American Gastroenterological Association, 2007
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease Start of enrollment: 2013 Sep 01
Publications & Presentations
PubMed
- 3 citationsA novel duodenal-release formulation of caraway oil and L-menthol is a safe, effective and well tolerated therapy for functional dyspepsia.Brian E Lacy, William D Chey, Michael S Epstein, Syed M Shah, Patrick Corsino
BMC Gastroenterology. 2022-03-07 - 3 citationsBowel preparation with 1L polyethylene glycol and ascorbate NER1006 doubles the chance to detect three or more adenomas in overweight or obese males.Michael P. Epstein, Juha Halonen, Prateek Sharma
Endoscopy International Open. 2021-08-16 - 4 citationsPatient experience with NER1006 as a bowel preparation for colonoscopy: a prospective, multicenter US survey.Brooks D. Cash, Mary Beth C Moncrief, Michael S. Epstein, David M. Poppers
BMC Gastroenterology. 2021-02-15
Press Mentions
- 36-Month Post-Marketing Surveillance Report for FDgard®, Now Available for Review at the American College of Gastroenterology (ACG) E-poster WebsiteOctober 26th, 2020
![For the Sixth Year in A Row, in A Survey of Gastroenterologists' Preferences for IBS Products, IBgard® Widens Its Already Preeminent "#1 Recommended"[1] Status](https://doximity-res.cloudinary.com/image/upload/v1548182778/uzlb8gndtry9za0cnw09.png)
For the Sixth Year in A Row, in A Survey of Gastroenterologists' Preferences for IBS Products, IBgard® Widens Its Already Preeminent "#1 Recommended"[1] StatusAugust 10th, 2020
Unprecedented 3-Year Safety Data Unveiled at Digestive Disease Week (DDW) Indicates No Pattern of Heartburn with IBgard®, an Advanced Technology Peppermint Oil, Contrary to Heartburn Issues with Older TechnologiesMay 5th, 2020- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
